Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
BACKGROUND
Postoperative bleeding may be complicated by failure to identify the site of bleeding, multiple bleeding points, and persistent hemorrhage despite surgical intervention.


METHODS
Activated recombinant factor VII was used successfully in a patient with life-threatening postsurgical bleeding after resection of two large extraperitoneal pelvic sarcomas.


CONCLUSIONS
In severe hemorrhage, hemostasis can be achieved with activated recombinant factor VII.
Daniloś
Jarosław
J
First Department of Gynecology, Medical University, Lublin, Poland. obgyn@panaceum.am.lublin.pl
Goral
Andrzej
A
Paluszkiewicz
Piotr
P
Przesmycki
Krzysztof
K
Kotarski
Jan
J
D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000601:surgery; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012509:Sarcoma / Q000601:surgery
D011994:Recombinant Proteins; D015942:Factor VIIa